While the factors contributing to linear versus classical psoriasis development in those using anti-TNF-α inhibitor therapies remains unclear, we present a case to add to the literature of a patient with HS that developed linear psoriasis in a Blaschkoid distribution felt to be induced by treatment with infliximab. This evidence concerns the gene TNF and psoriasis.